Related Experiment Videos
Serum cholesterol and older people
Insights
High serum cholesterol is linked to coronary heart disease (CHD) at all ages. Lipid-lowering treatment can reduce CHD morbidity and mortality, even though trials often exclude older patients and women.
Area of Science:
- Cardiovascular Medicine
- Public Health
Background:
- Serum cholesterol levels are a significant risk factor for coronary heart disease (CHD).
- Existing clinical trials demonstrate the benefits of lipid-lowering treatments in reducing CHD morbidity and mortality.
Purpose of the Study:
- To review the existing literature on serum cholesterol and coronary heart disease.
- To contextualize expert committee recommendations for cholesterol management in light of trial limitations.
Main Methods:
- Literature review of studies on serum cholesterol and coronary heart disease.
- Analysis of recommendations from UK and USA expert committees.
Main Results:
- Serum cholesterol is positively associated with coronary heart disease across all age groups.
- Lipid-lowering treatment has shown efficacy in reducing CHD morbidity and mortality in middle-aged men.
Conclusions:
- Despite trial exclusions, expert recommendations for cholesterol management encompass broader populations, including older patients and women.
- Further consideration of evidence is needed to fully contextualize cholesterol management guidelines for diverse populations.
Abstract:
Serum cholesterol is positively associated with coronary heart disease (CHD) at all ages. Evidence from trials in middle-aged men with CHD suggests that morbidity and mortality can be reduced after only a few years of lipid-lowering treatment. Although older patients and women have not been included in these trials, both UK and USA expert committees' recommendations on measurement and reduction of cholesterol have not excluded such people. The literature on this issue is reviewed in order to put these recommendations into context.